Ali's Taotian Supply Chain Company increased its capital to 50 million yuan, an increase of 400%. Tianyancha App shows that recently, Hangzhou Taotian Supply Chain Co., Ltd. has undergone industrial and commercial changes, and its registered capital has increased from 10 million yuan to 50 million yuan, an increase of 400%. At the same time, some key personnel have changed. Hangzhou Taotian Supply Chain Co., Ltd. was established in January 2016, and its legal representative is Zhang Bowen. Its business scope includes supply chain management services, professional design services, socio-economic consulting services, primary processing of edible agricultural products, primary processing of non-edible agricultural products, wholesale of aquatic products, acquisition of aquatic products, frozen processing of aquatic products, etc. It is wholly owned by Alibaba (China) Network Technology Co., Ltd.The OpenAI webpage shows that API, ChatGPT and Sora are all running normally.Treasury futures turned green for 30 years, and treasury futures turned down. The 30-year main contracts turned green and fell by 0.03% to 116.94. The 10-year main contract was reported at 108.17, and the increase narrowed to 0.02%.
Flying Pig: In 2024, the number of holiday businesses whose GMV exceeded 100 million yuan was three times that of last year. On December 12, Flying Pig said at the 2024 holiday business conference that under the positioning of the open platform, the business efficiency and business satisfaction of businesses continued to improve. In 2024, the number of travel agencies, amusement parks, cruise ships and other holiday businesses on the Flying Pig platform maintained double-digit growth year-on-year. The number of businesses with GMV exceeding 100 million yuan was three times that of last year, and the average order volume of gold medal merchants reached more than twice the market level, with a conversion rate about 20% higher.Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.On the 12th, the South Korean National Assembly voted to impeach the Minister of Justice Park Hyung-jae and the Director of the Police Department Zhao Zhihao.
Israeli: Community alarm sounded near Gaza.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)China Merchants Securities: Hisense's household appliances are obviously underestimated, and the safety cushion is thick, and it is rated as "strongly recommended". China Merchants Securities Research Report pointed out that the growth rate of Hisense's household appliances (000921.SZ) slowed down, showing the first year-on-year decline in nine quarters since 22Q3, and the market confidence was weak. The company is obviously underestimated, and the safety mat is thick. Looking horizontally, in 2025, the valuations of Hisense, Midea and Haier will be 10/13/13 times; Historically, the company's share price has been deeply adjusted since May this year, and the current valuation is at a lower level since the 22-year reform. Referring to the global valuation system, the steady-state PE hub of johnson controls/Carrier/Trane is 30/25/20 times, which is higher than the valuation of white power enterprises represented by Whirlpool and Electrolux. Hisense household appliances, as the standard of A-share central air conditioning, should enjoy a higher valuation than white power companies. The improvement of the company's bottom management promotes efficiency and cost reduction+the global operation competitiveness is constantly strengthened+the company's leading position is stable under the background of domestic substitution of central air conditioning, and it continues to be firmly optimistic about the company. It is estimated that the company's revenue will increase by +8%, +9% and +10% from 2024 to 2026, and its performance will increase by +15%, +14% and +16% respectively. Give a "strongly recommended" rating.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14